Cognito Therapeutics Appoints Christian Howell as Chief Commercial Officer
October 30, 2023 08:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, today announced the appointment of Christian Howell as Chief Commercial Officer (CCO). “I am looking forward to working with the team to build upon our commercial strategy, with the ultimate goal of making a meaningful difference in the lives of patients with neurodegenerative … Continue reading Cognito Therapeutics Appoints Christian Howell as Chief Commercial Officer